Dashboard
Manage Tickers

ANABANAPTYSBIO, INC

Nasdaq anaptysbio.com


$ 35.61 $ -0.32 (-0.91 %)    

Monday, 09-Sep-2024 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 35.575
$ 35.53 x 200
-- x --
-- - --
$ 13.36 - $ 41.31
142,564
na
976.51M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 03-07-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-04-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 03-05-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-08-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

insiders-buying-yum-china-and-2-other-stocks
Insiders Buying Yum China And 2 Other Stocks
08/19/2024 13:04:12

truist-securities-maintains-hold-on-anaptysbio-raises-price-target-to-30
Truist Securities Maintains Hold on Anapty...
08/15/2024 12:37:59

Truist Securities analyst John Lee maintains AnaptysBio (NASDAQ:ANAB) with a Hold and raises the price target from $20 to $30.

hc-wainwright--co-reiterates-buy-on-anaptysbio-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Anap...
08/14/2024 18:03:05

HC Wainwright & Co. analyst Emily Bodnar reiterates AnaptysBio (NASDAQ:ANAB) with a Buy and maintains $55 price target.

ubs-posts-upbeat-earnings-joins-victorias-secret-performance-food-group-kellanova-and-other-big-stocks-moving-higher-on-wednesday
UBS Posts Upbeat Earnings, Joins Victoria'...
08/14/2024 14:36:17

sp-500-rises-small-caps-outperform-as-july-consumer-price-index-fuels-fed-rate-cut-hopes-5-etfs-to-watch-wednesday
S&P 500 Rises, Small Caps Outperform As Ju...
08/14/2024 13:36:10

US inflation eases in July, keeping Fed rate cut hopes alive. Stocks rise, yields stable, dollar gains against yen. Tech and sm...

anaptysbio-announced-the-pricing-of-an-underwritten-offering-of-2750498-shares-of-its-common-stock-at-a-price-of-3650-per-share-representing-a-premium-of-around-10-to-anaptys-closing-price-on-aug-13-2024
AnaptysBio Announced The Pricing Of An Und...
08/14/2024 09:02:00

jp-morgan-maintains-overweight-on-anaptysbio-raises-price-target-to-75
JP Morgan Maintains Overweight on AnaptysB...
08/07/2024 17:06:49

JP Morgan analyst Anupam Rama maintains AnaptysBio (NASDAQ:ANAB) with a Overweight and raises the price target from $69 to $75.

4-analysts-assess-anaptysbio-what-you-need-to-know
4 Analysts Assess AnaptysBio: What You Nee...
08/06/2024 14:01:20

hc-wainwright--co-reiterates-buy-on-anaptysbio-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Anap...
08/06/2024 10:35:27

HC Wainwright & Co. analyst Emily Bodnar reiterates AnaptysBio (NASDAQ:ANAB) with a Buy and maintains $55 price target.

anaptysbio-q2-2024-adj-eps-171-misses-089-estimate-sales-1100m-miss-2430m-estimate
AnaptysBio Q2 2024 Adj EPS $(1.71) Misses ...
08/05/2024 20:30:33

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $(0.89) ...

anaptysbio-investigational-arthritis-drug-might-have-better-efficacy-profile-than-eli-lillys-analyst
AnaptysBio Investigational Arthritis Drug ...
07/22/2024 18:53:08

HC Wainwright initiated coverage on AnaptysBio with a Buy rating and a $55 price target. AnaptysBio focuses on immunology thera...

hc-wainwright--co-initiates-coverage-on-anaptysbio-with-buy-rating-announces-price-target-of-55
HC Wainwright & Co. Initiates Coverage On ...
07/22/2024 10:46:39

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on AnaptysBio (NASDAQ:ANAB) with a Buy rating and announces ...

jp-morgan-upgrades-anaptysbio-to-overweight-raises-price-target-to-69
JP Morgan Upgrades AnaptysBio to Overweigh...
07/19/2024 13:03:56

JP Morgan analyst Anupam Rama upgrades AnaptysBio (NASDAQ:ANAB) from Neutral to Overweight and raises the price target from ...

the-analyst-landscape-7-takes-on-anaptysbio
The Analyst Landscape: 7 Takes On AnaptysBio
05/10/2024 21:01:14

wedbush-reiterates-outperform-on-anaptysbio-maintains-34-price-target
Wedbush Reiterates Outperform on AnaptysBi...
05/10/2024 13:50:23

Wedbush analyst David Nierengarten reiterates AnaptysBio (NASDAQ:ANAB) with a Outperform and maintains $34 price target.

anaptysbio-q1-2024-adj-eps-164-misses-157-estimate-sales-7180m-beat-3967m-estimate
AnaptysBio Q1 2024 Adj EPS $(1.64) Misses ...
05/09/2024 21:13:12

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.64) per share which missed the analyst consensus estimate of $(1.57) ...

anaptys-top-line-gemini-2-phase-3-clinical-trial-results-of-imsidolimab-in-generalized-pustular-psoriasis-patients-who-received-a-single-dose-of-750mg-iv-imsidolimab-53-achieved-a-gpp-physician-global-assessment-score-of-01-clear-or-almost-clear-skin-at-week-4
Anaptys Top-Line GEMINI-2 Phase 3 Clinical...
05/09/2024 21:06:19

All eight patients from GEMINI-1 who responded to a single intravenous (IV) imsidolimab dose and were subsequently re-randomize...

anaptys-to-receive-50m-upfront-cash-payment-from-sagard-healthcare-from-amended-agreement-in-exchange-for-additional-jemperli-royalties
Anaptys To Receive $50M Upfront Cash Payme...
05/09/2024 21:04:52

Anaptys to receive $50 million upfront cash payment from Sagard Healthcare Prior agreement amended to now expire once Sagard re...

leerink-partners-initiates-coverage-on-anaptysbio-with-outperform-rating-announces-price-target-of-47
Leerink Partners Initiates Coverage On Ana...
04/16/2024 16:10:47

Leerink Partners analyst David Risinger initiates coverage on AnaptysBio (NASDAQ:ANAB) with a Outperform rating and announce...

why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Fastenal Shares Are Trading Lower By A...
04/11/2024 17:33:07

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION